NADAC acquisition cost data for GENERLAC 10 GM/15 ML SOLUTION. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 60432003816 | $0.0149 | 2022-12-21 | Rx |
| 60432003816 | $0.0149 | 2022-12-21 | Rx |
Generic: Lactulose | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $3.1M | 117,413 | 45,925 | $0.0245 |
| 2020 | $1.7M | 54,339 | 23,047 | $0.0231 |
| 2021 | $1.2M | 38,341 | 16,257 | $0.0234 |
| 2022 | $509.3K | 16,425 | 8,131 | $0.0255 |
| 2023 | $69.6K | 3,099 | 1,356 | $0.0261 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $19.4K | 997 | 310 |
| Florida | $5.1K | 228 | 135 |
| Maryland | $4.3K | 109 | 26 |
| Texas | $4.3K | 201 | 112 |
| California | $4.0K | 191 | 87 |
| Michigan | $3.2K | 156 | 52 |
| Georgia | $2.6K | 77 | 38 |
| Connecticut | $2.4K | 44 | 25 |
| New Jersey | $2.4K | 103 | 36 |
| Pennsylvania | $2.0K | 102 | 23 |
| Tennessee | $1.8K | 57 | 40 |
| Alabama | $1.7K | 74 | 43 |
| Arkansas | $1.4K | 16 | 11 |
| Illinois | $1.4K | 55 | 39 |
| North Dakota | $1.3K | 125 | 19 |
| New Mexico | $1.1K | 64 | 39 |
| Arizona | $1.1K | 39 | 28 |
| Mississippi | $915.04 | 46 | 23 |
| Virginia | $836.68 | 26 | 18 |
| Louisiana | $758.44 | 57 | 24 |
| Washington | $642.29 | 28 | 23 |
| Kentucky | $596.26 | 21 | 13 |
| North Carolina | $535.11 | 30 | 18 |
| Oklahoma | $508.63 | 34 | 27 |
| Massachusetts | $504.53 | 20 | 14 |
| Utah | $462.30 | 18 | N/A |
| Kansas | $391.08 | 13 | 11 |
| Puerto Rico | $356.93 | 29 | 23 |
| South Carolina | $345.59 | 16 | 15 |
| Wisconsin | $243.52 | 11 | 11 |
| Iowa | $179.75 | 12 | N/A |
| Ohio | $172.73 | 17 | 15 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.